Advertisement
Screener

GERON CORP (GERN) Share-based Goods and Nonemployee Services Transaction, Modification of Terms, Incremental Compensation Cost

1.5 / 5 stars · 23/76 Roast Me

GERON CORP Share-based Goods and Nonemployee Services Transaction, Modification of Terms, Incremental Compensation Cost

GERON CORP (GERN) reported Share-based Goods and Nonemployee Services Transaction, Modification of Terms, Incremental Compensation Cost of $0 for the 12-month period ending 2011-12-31, per its 10-K filed 2012-03-07.

Discontinued › Expense Statement › Operating Expenses

us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionModificationOfTermsIncrementalCompensationCost · last filed 2012-03-07

  • GERON CORP share-based goods and nonemployee services transaction, modification of terms, incremental compensation cost for fiscal 2011 was $0.00.
  • GERON CORP share-based goods and nonemployee services transaction, modification of terms, incremental compensation cost for fiscal 2010 was $0.00, a 100.00% decline from fiscal 2009.
  • GERON CORP share-based goods and nonemployee services transaction, modification of terms, incremental compensation cost for fiscal 2009 was $190.00K.
Period endShare-based Goods and Nonemployee Services Transaction, Modification of Terms, Incremental Compensation Cost 12 month
2011-12-31$0.00
10-K · filed 2012-03-07
2010-12-31$0.00
10-K · filed 2012-03-07
2009-12-31$190.00K
10-K · filed 2012-03-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
Aclaris Therapeutics, Inc. (ACRS)United States$0.792B-9.78
Olema Pharmaceuticals, Inc. (OLMA)United States$0.790B-5.35
GYRE THERAPEUTICS, INC. (GYRE)United States$0.818B-24.71
LEXICON PHARMACEUTICALS, INC. (LXRX)United States$0.823B-17.48
Wave Life Sciences, Inc. (WVE)$0.780B-5.56
Obsidian Therapeutics, Inc. (OBX)United States$0.829B
Immix Biopharma, Inc. (IMMX)United States$0.837B-18.44
Design Therapeutics, Inc. (DSGN)United States$0.766B-12.78
Avalo Therapeutics, Inc. (AVTX)United States$0.842B-9.74
Faeth Therapeutics, Inc. (FTH)United States$0.750B